Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge-Marie Obdeijn

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
AJR. American Journal of Roentgenology|January 25, 2013
Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgeryInge-Marie Obdeijn, Madeleine M A Tilanus-Linthorst, Sandra Spronk, et al.
Breast Cancer Research and Treatment|April 26, 2020
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriersInge-Marie Obdeijn, Ritse M Mann, Claudette C E Loo, et al.
Journal of Surgical Oncology|October 22, 2014
Preoperative prediction of cosmetic results in breast conserving surgeryElvira L Vos, Anton H J Koning, Inge-Marie Obdeijn, et al.
Breast Cancer Research and Treatment|January 28, 2026
Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapyEline M J Lammers, Jeanne Beens-van Dijk, Annelies Nijdam, et al.
Cancer Biology & Therapy|January 16, 2014
Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomyVictorien Mt van Verschuer, Bernadette Am Heemskerk-Gerritsen, Carolien Hm van Deurzen, et al.
Cancer|April 15, 2006
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trialsMadeleine M A Tilanus-Linthorst, Inge-Marie Obdeijn, Wim C J Hop, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Journal of the National Cancer Institute|August 14, 2013
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imagingSepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2005
Hereditary breast cancer growth rates and its impact on screening policyMadeleine M A Tilanus-Linthorst, Mieke Kriege, Carla Boetes, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
AJR. American Journal of Roentgenology|January 25, 2013
Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgeryInge-Marie Obdeijn, Madeleine M A Tilanus-Linthorst, Sandra Spronk, et al.
Breast Cancer Research and Treatment|April 26, 2020
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriersInge-Marie Obdeijn, Ritse M Mann, Claudette C E Loo, et al.
Journal of Surgical Oncology|October 22, 2014
Preoperative prediction of cosmetic results in breast conserving surgeryElvira L Vos, Anton H J Koning, Inge-Marie Obdeijn, et al.
Breast Cancer Research and Treatment|January 28, 2026
Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapyEline M J Lammers, Jeanne Beens-van Dijk, Annelies Nijdam, et al.
Cancer Biology & Therapy|January 16, 2014
Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomyVictorien Mt van Verschuer, Bernadette Am Heemskerk-Gerritsen, Carolien Hm van Deurzen, et al.
Cancer|April 15, 2006
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trialsMadeleine M A Tilanus-Linthorst, Inge-Marie Obdeijn, Wim C J Hop, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Journal of the National Cancer Institute|August 14, 2013
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imagingSepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2005
Hereditary breast cancer growth rates and its impact on screening policyMadeleine M A Tilanus-Linthorst, Mieke Kriege, Carla Boetes, et al.
Pageof 4